On June 5, 2024, Eli Lilly and Company announced that Ms. Anat Ashkenazi resigned as executive vice president of the Company to pursue another career opportunity outside of the pharmaceutical industry. Ms. Ashkenazi will remain at the Company through the end of July 2024 to facilitate the transition of her responsibilities.